IP Group

IP Group is a London-based corporate firm that provides financial, strategic, and commercial expertise to clients internationally. Founded in 2001, the company focuses on creating value through the commercialisation of intellectual property derived from research-intensive institutions. It manages the end-to-end process of identifying viable IP, developing or partnering to build value, and establishing commercial arrangements that translate scientific advances into practical products and businesses. IP Group combines industry insight and financial experience to support science- and technology-based ventures, offering capital as well as strategic guidance to help companies grow and accelerate the impact of research. Its work spans clean technology, life sciences, and other deep technology sectors, with a track record of backing and developing ventures that aim to deliver tangible societal and economic outcomes.

Alan Aubrey

CEO, Executive Director and Member of the Board of Directors

David Baynes

Chief Financial and Operating Officer and Board Member

Jon Edington

Partner, Technology

Ben Murphey

Investment Director

Ben Murphy

Investment Director, Kiko Ventures

Mark Reilly Ph.D

Managing Partner, Technology

Greg Smith

CEO

Lee Thornton Ph.D

Partner, Technology

Robert Trezona Ph.D

Partner and Head of Cleantech

Past deals in Great Britain

AccelerComm

Series B in 2023
AccelerComm is a semiconductor IP-core company that provides forward error correction and channel coding solutions for wireless communications. It develops hardware-friendly encoders and decoders, including 3GPP-compliant encoding/decoding chains, turbo decoders, LDPC chains, and polar encoder/decoder facilities, to accelerate next-generation wireless systems and overcome bottlenecks in error correction decoding caused by noise and interference. The company focuses on patent-pending channel coding technology that enhances data throughput and efficiency for 3GPP-based networks and related applications, including base stations and mobile devices. Headquartered in Southampton, United Kingdom, AccelerComm aims to enable cost-effective, high-performance digital communications across multiple standards.

Deep Render

Series A in 2023
Deep Render is a London-based AI startup spun out from Imperial College London's Department of Computing. It develops AI-powered video and image compression technology that leverages deep learning, density estimation, unsupervised learning, and quantum techniques to improve compression efficiency. The company has proprietary, patented technology in media and biological image compression, with state-of-the-art results delivering at least a 50% efficiency gain over previous standards.

SLAMcore Limited

Series A in 2022
SLAMcore develops simultaneous localization and mapping (SLAM) solutions for augmented/virtual reality, robotics, and autonomous vehicles. Its technology enables moving robots to localize, navigate, and understand unfamiliar surroundings using visual SLAM, sensor fusion, and event camera SLAM. The company's ETAM 2D and ETAM 3D methods demonstrate real-time, high dynamic range, and resolution intensity for event-based cameras. SLAMcore licenses its algorithms for smart technology like drones and self-driving vehicles.

GripAble

Series A in 2022
GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.

First Light Fusion

Series C in 2022
First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Bramble Energy

Series B in 2022
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

Hinge Health

Series E in 2021
Hinge Health is a digital health company that designs and delivers technology-enabled musculoskeletal care for employees and self-insured employers. The platform combines wearable sensors, computer vision and a clinical team to provide digital physical therapy, guidance on behavior change, and access to orthopedic expertise via a single app. It targets back, neck, shoulder and joint pain and aims to improve access to high-quality care while reducing costs for clients. The solution supports self-management with remote monitoring and personalized programs, enabling physical therapists, health coaches and surgeons to coordinate care. Founded in 2015 and headquartered in San Francisco, it serves businesses and individuals seeking scalable MSK treatment and prevention.

Monolith AI

Series A in 2021
Monolith AI Limited is a software company based in London, United Kingdom, founded in 2016. The company specializes in developing algorithms that integrate engineering simulations with machine learning techniques to enhance the engineering design process. By leveraging existing simulation and test data, Monolith AI enables engineers to predict the behavior of new products more accurately, thereby optimizing research and development efforts. This approach reduces the need for extensive simulations, tests, and prototypes, allowing companies to accelerate product development and improve overall product quality. Monolith AI was previously known as UQuant Limited until it rebranded in June 2018.

AccelerComm

Series A in 2020
AccelerComm is a semiconductor IP-core company that provides forward error correction and channel coding solutions for wireless communications. It develops hardware-friendly encoders and decoders, including 3GPP-compliant encoding/decoding chains, turbo decoders, LDPC chains, and polar encoder/decoder facilities, to accelerate next-generation wireless systems and overcome bottlenecks in error correction decoding caused by noise and interference. The company focuses on patent-pending channel coding technology that enhances data throughput and efficiency for 3GPP-based networks and related applications, including base stations and mobile devices. Headquartered in Southampton, United Kingdom, AccelerComm aims to enable cost-effective, high-performance digital communications across multiple standards.

Bramble Energy

Series A in 2020
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

SAM Labs

Series A in 2019
SAM Labs Limited is an education technology company based in London, United Kingdom, established in 2014. It specializes in providing educators with resources that enhance teaching and learning experiences, particularly in the areas of coding and computational skills. The company offers a range of products including wireless electronic blocks, such as buttons, sensors, motors, and sliders, which can be connected via an intuitive software application called SAM Space. This platform allows students to visualize and code the blocks, enabling them to create interactive projects and engage in hands-on learning. SAM Labs also supplies curriculum-based lesson plans and in-classroom support to facilitate STEAM education, making coding accessible and fun. Its course kits and electronic products are available for purchase online, helping educators deliver comprehensive and engaging lessons across various subjects.

Inivata

Series B in 2019
Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, that specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment. Founded in 2014, Inivata has developed TAm-Seq technology, which enables the detection and analysis of genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples. This innovative approach, known as liquid biopsy, provides a significant advancement over traditional invasive biopsies by allowing for easier detection, monitoring, and treatment of cancer. Inivata's platform aims to assist oncologists in making informed treatment decisions by improving the understanding of cancer dynamics, including monitoring treatment responses and detecting relapses. The company has established a strategic collaboration with NeoGenomics, Inc. to further its mission in the field of cancer genomics.

AccelerComm

Seed Round in 2019
AccelerComm is a semiconductor IP-core company that provides forward error correction and channel coding solutions for wireless communications. It develops hardware-friendly encoders and decoders, including 3GPP-compliant encoding/decoding chains, turbo decoders, LDPC chains, and polar encoder/decoder facilities, to accelerate next-generation wireless systems and overcome bottlenecks in error correction decoding caused by noise and interference. The company focuses on patent-pending channel coding technology that enhances data throughput and efficiency for 3GPP-based networks and related applications, including base stations and mobile devices. Headquartered in Southampton, United Kingdom, AccelerComm aims to enable cost-effective, high-performance digital communications across multiple standards.

Yoyo Wallet

Series C in 2018
Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.

Garrison

Series B in 2018
Garrison Technology Limited, established in London, UK, in 2014, specializes in enterprise cybersecurity solutions. The company focuses on developing innovative anti-malware technology designed to efficiently mitigate high-impact internet-borne targeted attacks, a significant threat to modern organizations. Garrison's unique approach enables secure internet connectivity, enhances user experience, and ensures scalability for enterprises.

Dukosi

Venture Round in 2018
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

OxSyBio

Series A in 2018
OxSyBio Ltd. is a biotechnology company based in London, United Kingdom, specializing in the development of advanced 3D printing techniques for creating tissue-like and functional tissues intended for medical research and clinical applications. Founded in 2014, the company focuses on innovative methods that utilize three-dimensional networks of lipid monolayer aqueous droplets, which can conduct electrical signals along designated pathways and self-fold into intricate structures. These engineered tissues aim to facilitate organ repair or replacement, supporting precision medicine initiatives. The technology builds upon pioneering research from Professor Hagan Bayley's group at the University of Oxford, emphasizing the integration of chemical and synthetic biology in the field of regenerative medicine.

Touchstone Innovations

Acquisition in 2017
Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.

Ionix Advanced Technologies

Venture Round in 2017
Ionix Advanced Technologies designs and manufactures high-temperature piezoelectric devices and materials, offering sensors, actuators and transducers based on novel high-temperature piezoelectric materials and anisotropic ceramics to reduce ultrasonic crosstalk and improve acoustic transmission. It serves industrial processes in aerospace, oil and gas, nuclear power, automotive, and ultrasound and nondestructive testing markets, focusing on high-performance systems that operate reliably in extreme environments, including high temperatures and radiation. The company enables continuous monitoring and safer, more efficient operation of equipment. Founded in 2011 and based in Leeds, United Kingdom.

Eight19

Venture Round in 2017
Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.

Creavo Medical Technologies

Series B in 2017
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.

Saw DX

Venture Round in 2017
SAW DX Ltd is a technology development company based in Glasgow, United Kingdom, that specializes in designing and manufacturing point-of-care (POC) diagnostic devices. The company leverages innovative Acoustic-Flow technology, which utilizes surface acoustic waves to drive diagnostic tests by manipulating fluid movement and microstructures on disposable chips. This approach allows for on-chip sample processing without the need for preprocessing, streamlining the diagnostic process. SAW DX's product offerings include prototypes for diagnosing sexually transmitted infections, demonstrator readers and cartridges for tuberculosis assays, and platforms for enriching parasites and performing molecular detection with low-cost disposable chips. The company primarily serves life sciences and diagnostics organizations seeking to enhance their diagnostic capabilities through advanced POC solutions. Incorporated in 2013, SAW DX aims to provide faster, more efficient, and cost-effective diagnostic methods for infectious diseases.

Dukosi

Series A in 2017
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Parkwalk Advisors

Acquisition in 2016
Parkwalk Advisors is a London-based venture capital firm that focuses on UK technology companies with IP backing, primarily those spun out from UK universities. The firm invests across seed to growth stages, including late-stage rounds, and is stage-agnostic, aiming to support unlisted companies with freedom to operate. It concentrates on companies originating from university research, especially in Cambridge and across the UK, and targets sectors such as healthcare, energy, materials, technology, artificial intelligence, big data, life sciences, cleantech, medtech, quantum computing, and the apps ecosystem. Typical investments range from about £0.3 million to £10 million, with capital structures kept in a single share class, and the firm may provide equity or debt financings. Investments are generally planned over a three- to eight-year horizon.

AccelerComm

Seed Round in 2016
AccelerComm is a semiconductor IP-core company that provides forward error correction and channel coding solutions for wireless communications. It develops hardware-friendly encoders and decoders, including 3GPP-compliant encoding/decoding chains, turbo decoders, LDPC chains, and polar encoder/decoder facilities, to accelerate next-generation wireless systems and overcome bottlenecks in error correction decoding caused by noise and interference. The company focuses on patent-pending channel coding technology that enhances data throughput and efficiency for 3GPP-based networks and related applications, including base stations and mobile devices. Headquartered in Southampton, United Kingdom, AccelerComm aims to enable cost-effective, high-performance digital communications across multiple standards.

Stratium

Seed Round in 2016
Stratium Limited is a manufacturer of mid-infrared quantum cascade lasers (QCL) based in Cardiff, United Kingdom. Established in 2015, the company specializes in providing compound semiconductor lasers to original equipment manufacturers (OEM) for various commercial applications. Stratium's QCLs support critical functions in environmental monitoring, vehicle emission tracking, vehicle collision avoidance, breath diagnostics, and petrochemical process oversight. The lasers are designed to deliver precise mid-infrared emissions essential for advanced gas analysis, utilizing innovative wavelength selection technology that enhances their compactness, stability, and performance. These features make Stratium's products suitable for sensitive detection of molecular species employing techniques such as cavity ring-down spectroscopy, cavity enhanced absorption spectrometry, and photoacoustic spectroscopy, enabling clients to effectively monitor airborne substances.

Dukosi

Venture Round in 2015
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Seren Photonics

Venture Round in 2015
Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

First Light Fusion

Venture Round in 2015
First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Ionix Advanced Technologies

Series A in 2015
Ionix Advanced Technologies designs and manufactures high-temperature piezoelectric devices and materials, offering sensors, actuators and transducers based on novel high-temperature piezoelectric materials and anisotropic ceramics to reduce ultrasonic crosstalk and improve acoustic transmission. It serves industrial processes in aerospace, oil and gas, nuclear power, automotive, and ultrasound and nondestructive testing markets, focusing on high-performance systems that operate reliably in extreme environments, including high temperatures and radiation. The company enables continuous monitoring and safer, more efficient operation of equipment. Founded in 2011 and based in Leeds, United Kingdom.

Relitect

Seed Round in 2015
Relitect Limited is a technology company based in Motherwell, United Kingdom, focused on developing innovative diagnostic solutions for the life sciences industry. Founded in 2014, Relitect specializes in a novel assay platform that enables label-free electrochemical detection of binding events. This proprietary technology allows for the highly sensitive analysis of proteins, small molecules, and nucleic acids, making it suitable for clinical diagnostics and research applications. By utilizing small sample volumes and a multiplexed format, Relitect's technology minimizes sample interference and eliminates the potential for cross-talk between labeled reagents, enhancing the accuracy of biomarker detection.

Dukosi

Venture Round in 2014
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Eight19

Venture Round in 2014
Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.

Diurnal

Venture Round in 2014
Diurnal Group plc is a specialty pharmaceutical company based in Cardiff, United Kingdom, that specializes in developing hormone therapeutics for the treatment of chronic endocrine conditions. Founded in 2004, the company aims to provide innovative solutions for conditions such as congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Diurnal's notable products include Alkindi, a replacement therapy for pediatric adrenal insufficiency, and Chronocort, which has completed Phase III clinical trials for adrenal insufficiency and congenital adrenal hyperplasia. The company is also advancing its early-stage pipeline with products such as Native Oral Testosterone for hypogonadism, a siRNA therapy for adrenocorticotropin-dependent Cushing's syndrome, and a modified-release preparation of T3 hormone for hypothyroidism. Diurnal's research emphasizes circadian-based endocrinology, focusing on physiological treatment regimes to address the needs of patients with rare and chronic endocrine disorders.

Givey

Seed Round in 2014
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Seren Photonics

Venture Round in 2014
Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

OxSyBio

Seed Round in 2014
OxSyBio Ltd. is a biotechnology company based in London, United Kingdom, specializing in the development of advanced 3D printing techniques for creating tissue-like and functional tissues intended for medical research and clinical applications. Founded in 2014, the company focuses on innovative methods that utilize three-dimensional networks of lipid monolayer aqueous droplets, which can conduct electrical signals along designated pathways and self-fold into intricate structures. These engineered tissues aim to facilitate organ repair or replacement, supporting precision medicine initiatives. The technology builds upon pioneering research from Professor Hagan Bayley's group at the University of Oxford, emphasizing the integration of chemical and synthetic biology in the field of regenerative medicine.

Creavo Medical Technologies

Seed Round in 2014
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.

Ridee

Seed Round in 2013
Ridee Ltd. is a food delivery service based in London, United Kingdom, established in 2013. The company provides a platform for consumers to browse menus and order food from a variety of restaurants and stores through its website and mobile application, Jinn, which is compatible with both iPhones and Android devices. Ridee manages the purchasing and delivery of the ordered food, facilitating convenience for its users. Since December 2017, Ridee Ltd. has operated as a subsidiary of Rico Logistics Ltd.

Verticly

Seed Round in 2013
Verticly, established in 2014 and headquartered in London, offers a SaaS platform that bridges online and offline customer data for FMCG brands, retailers, and manufacturers. It specializes in omni-channel marketing, enabling real-time, personalized engagement with consumers. The platform facilitates data exchange, channel attribution, vouchering, and targeted messaging, driving purchase decisions and enhancing customer experiences.

Givey

Seed Round in 2012
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Adludio

Seed Round in 2012
Adludio is a pioneering advertising company that specializes in interactive, AI-powered mobile advertising solutions. Founded in London in 2012, the company partners with international publishers and brands to deliver engaging, touch-enabled digital advertisements across various platforms. Adludio's innovative approach combines data science and learning science to create compelling brand experiences.

Fantoo

Seed Round in 2012
Fantoo Ltd., established in 2012 and based in Bracknell, UK, specializes in developing an online platform that enhances productivity by prioritizing and organizing emails and messages. Leveraging data analysis and artificial intelligence, the platform connects users with relevant people, files, and information feeds, consolidating tasks into a single, actionable list. It empowers users to focus on important messages and turn them into actions, providing a comprehensive, distraction-free workspace for managing daily tasks and appointments.

Seren Photonics

Venture Round in 2012
Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

Givey

Seed Round in 2012
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Givey

Seed Round in 2011
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

First Light Fusion

Venture Round in 2011
First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Crysalin

Series A in 2011
Crysalin Limited is a research and development company based in London, United Kingdom, founded in June 2007. It specializes in crysalin lattice technology, which has been developed from patented research conducted at the Oxford University Laboratory of Molecular Biophysics since 2002. The company's primary focus is on crysalins, a protein-based nanotechnology that significantly enhances protein structure determination, particularly for challenging macromolecular targets such as membrane proteins and flexible soluble proteins. By imposing order on these complex structures, crysalins enable advanced imaging techniques like X-ray and electron microscopy to accurately resolve three-dimensional molecular structures. In addition to protein structure determination, Crysalin's technology holds potential applications in biosensor development and optoelectronics, expanding its impact in the field of molecular research.

Seren Photonics

Seed Round in 2010
Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

TheraGenetics

Series A in 2007
TheraGenetics was spun out of King's College London in April 2006. Their technology is based upon pharmacogenetics; the study of genetic factors involved in influencing an individual's response to drug treatments. The strong foundation of TheraGenetics stems from the founding team's long commitment to pharmacogenetics that has situated us at the cutting edge of personalised medicine. Under the umbrella of the Institute of Psychiatry at King's College London, the founding team translated 15 years of research into the commercial world by developing the first pharmacogenetic test for response prediction in psychiatry. In 2005, this test which focuses on the schizophrenia treatment clozapine, was successfully licensed by King's College London to a major UK laboratory who have successfully brought the test to market in 2006. Based on this achievement and the overwhelming enthusiasm for personalised medicine solutions, King's College London, the academic founders and the London based venture firm IPGroup PLC launched TheraGenetics in April 2006. TheraGenetics unique knowledge and experience in CNS disorders extends from the bench to the bedside. The ultimate clinical utility has been a priority consideration at all stages of their test development; their clinical team knows what is required at the patient care interface and they develop tests accordingly. The TheraGenetic's team has a threshold of knowledge and experience spanning the whole test development process that is now allowing us to rapidly advance their work in the field of pharmacogenetic response prediction.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.